299 related articles for article (PubMed ID: 1914843)
21. Review of the in vitro antibacterial activity of cefprozil, a new oral cephalosporin.
Thornsberry C
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S189-94; discussion S195-6. PubMed ID: 1617037
[TBL] [Abstract][Full Text] [Related]
22. Comparative in vitro activity of the new oral cephalosporin Bay v 3522 against aerobic and anaerobic bacteria.
Rylander M; Nord CE; Norrby SR
Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):777-82. PubMed ID: 2261923
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.
Wise R; Andrews JM; Ashby JP; Thornber D
Antimicrob Agents Chemother; 1990 May; 34(5):813-8. PubMed ID: 2360820
[TBL] [Abstract][Full Text] [Related]
24. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
Pruksachatvuthi S; Aswapokee N; Aswapokee P
J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Hamilton-Miller JM; Brumfitt W
Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens.
Scriver SR; Willey BM; Low DE; Simor AE
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):646-52. PubMed ID: 1396778
[TBL] [Abstract][Full Text] [Related]
27. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
28. Comparative in-vitro activity of a new oral carbacephem, LY163892.
Howard AJ; Dunkin KT
J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
[TBL] [Abstract][Full Text] [Related]
29. [Cefuroxim, a new beta-lactamase stable cephalosporin].
Simon C
Schweiz Med Wochenschr; 1978 Sep; 108(36):1398-403. PubMed ID: 309178
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
Chin NX; Zhang YX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
[TBL] [Abstract][Full Text] [Related]
31. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods.
Jones RN; Pfaller MA; Jacobs MR; Appelbaum PC; Fuchs PC
Diagn Microbiol Infect Dis; 2001; 41(1-2):1-14. PubMed ID: 11687308
[TBL] [Abstract][Full Text] [Related]
32. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
Ergova R; K'oleian E; Kharalambieva Ia; Mitov I; Docheva Iu
Vutr Boles; 2000; 32(1):13-7. PubMed ID: 11195191
[TBL] [Abstract][Full Text] [Related]
33. The in-vitro activity of faropenem, a novel oral penem.
Woodcock JM; Andrews JM; Brenwald NP; Ashby JP; Wise R
J Antimicrob Chemother; 1997 Jan; 39(1):35-43. PubMed ID: 9044026
[TBL] [Abstract][Full Text] [Related]
34. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains.
Li Q; Lee JY; Castillo R; Hixon MS; Pujol C; Doppalapudi VR; Shepard HM; Wahl GM; Lobl TJ; Chan MF
Antimicrob Agents Chemother; 2002 May; 46(5):1262-8. PubMed ID: 11959554
[TBL] [Abstract][Full Text] [Related]
35. In-vitro activity and beta-lactamase stability of LY163892.
Cao C; Chin NX; Neu HC
J Antimicrob Chemother; 1988 Aug; 22(2):155-65. PubMed ID: 3263352
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of BMY-28100, a new oral cephalosporin.
Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of BAY v 3522, a new cephalosporin for oral administration.
Hodges TL; Eliopoulos GM; Klimm K; Moellering RC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1849-54. PubMed ID: 2285305
[TBL] [Abstract][Full Text] [Related]
38. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
Wise R; Andrews JM; Thornber D
J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
Yu KW; Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
[TBL] [Abstract][Full Text] [Related]
40. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
Wise R; Andrews JM; Ashby JP; Thornber D
Diagn Microbiol Infect Dis; 1991; 14(1):45-52. PubMed ID: 2013210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
